1832 Asset Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

1832 Asset Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1	Closed	–	–	746
2018 Q2	$0	Hold	1	–	–	﹤0.01%	753
2018 Q1	$0	Hold	1	–	–	﹤0.01%	768
2017 Q4	$0	Sell	1 -1,001	-100%	-$9.09K	﹤0.01%	768
2017 Q3	$10K	Buy	1,002 +1	+0.1%	+$14	﹤0.01%	615
2017 Q2	$21K	Hold	1,001	–	–	﹤0.01%	588
2017 Q1	$25K	Buy	+1,001	New	+$25.8K	﹤0.01%	623
2016 Q4	–	Sell	-1,001	Closed	-$21K	–	780
2016 Q3	$21K	Hold	1,001	–	–	﹤0.01%	573
2016 Q2	$16K	Hold	1,001	–	–	﹤0.01%	588
2016 Q1	$20K	Hold	1,001	–	–	﹤0.01%	529
2015 Q4	$20K	Hold	1,001	–	–	﹤0.01%	552
2015 Q3	$18K	Hold	1,001	–	–	﹤0.01%	537
2015 Q2	$29K	Buy	1,001 +1,000	+100,000%	+$30.2K	﹤0.01%	558
2015 Q1	$0	Hold	1	–	–	﹤0.01%	712
2014 Q4	$0	Hold	1	–	–	﹤0.01%	677
2014 Q3	$0	Hold	1	–	–	﹤0.01%	673
2014 Q2	$0	Hold	1	–	–	﹤0.01%	676
2014 Q1	$0	Buy	+1	New	+$40	﹤0.01%	651

Other funds holding IPCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

1832 Asset Management's IPCI Position: Q3 2018 in Review

1832 Asset Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 1 share.

1832 Asset Management first reported a position in IPCI in Q1 2014 and held it in 17 quarters. The position peaked at $29K in Q2 2015. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

1832 Asset Management reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
1832 Asset Management sold 1 Intellipharmaceuticals International Inc. share in Q3 2018.
1832 Asset Management first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and held it in 17 quarters.
1832 Asset Management's Intellipharmaceuticals International Inc. position peaked at $29K in Q2 2015.
10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on 1832 Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.